Lv4
570 积分 2025-02-14 加入
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
2天前
已完结
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
2天前
已完结
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
14天前
已完结
Cholecystokinin B receptor antagonists for the treatment of depression via blocking long-term potentiation in the basolateral amygdala
2个月前
已完结
A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder
2个月前
已完结
[Explanation of the experts consensus on diagnosis and treatment of laryngeal leukoplakia]
4个月前
已完结
Generative AI: driving productivity and scientific breakthroughs in pharmaceutical R&D
5个月前
已完结
Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trial
5个月前
已完结
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial
5个月前
已完结
Synthetic lethality and cancer
5个月前
已完结
皖公网安备34019202002308
